Grantham, Mayo, Van Otterloo & Co (GMO)’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,591
| Closed | -$1.93M | – | 634 |
|
|
2025
Q1 | $1.93M | Buy |
+26,591
| New | +$1.93M | 0.01% | 381 |
|
|
2023
Q1 | – | Sell |
-3,000
| Closed | -$224K | – | 719 |
|
|
2022
Q4 | $224K | Buy |
+3,000
| New | +$224K | ﹤0.01% | 668 |
|
|
2022
Q2 | – | Sell |
-6,082
| Closed | -$716K | – | 770 |
|
|
2022
Q1 | $716K | Buy |
+6,082
| New | +$716K | ﹤0.01% | 559 |
|
|
2021
Q2 | – | Sell |
-33,763
| Closed | -$2.82M | – | 759 |
|
|
2021
Q1 | $2.82M | Sell |
33,763
-152,900
| -82% | -$12.8M | 0.02% | 422 |
|
|
2020
Q4 | $17M | Buy |
186,663
+179,064
| +2,356% | +$16.3M | 0.1% | 137 |
|
|
2020
Q3 | $607K | Buy |
+7,599
| New | +$607K | ﹤0.01% | 601 |
|
|
2016
Q2 | – | Sell |
-447,984
| Closed | -$13.2M | – | 574 |
|
|
2016
Q1 | $13.2M | Sell |
447,984
-197,370
| -31% | -$5.8M | 0.05% | 213 |
|
|
2015
Q4 | $17M | Sell |
645,354
-102,366
| -14% | -$2.69M | 0.06% | 162 |
|
|
2015
Q3 | $17.7M | Sell |
747,720
-14,694
| -2% | -$348K | 0.06% | 152 |
|
|
2015
Q2 | $18.1M | Sell |
762,414
-42,000
| -5% | -$997K | 0.06% | 143 |
|
|
2015
Q1 | $19.1M | Buy |
804,414
+39,600
| +5% | +$940K | 0.06% | 140 |
|
|
2014
Q4 | $16.2M | Sell |
764,814
-139,176
| -15% | -$2.95M | 0.04% | 156 |
|
|
2014
Q3 | $15.4M | Sell |
903,990
-100,686
| -10% | -$1.71M | 0.04% | 170 |
|
|
2014
Q2 | $14.4M | Buy |
1,004,676
+684,000
| +213% | +$9.79M | 0.04% | 174 |
|
|
2014
Q1 | $3.96M | Sell |
320,676
-87,246
| -21% | -$1.08M | 0.01% | 328 |
|
|
2013
Q4 | $4.47M | Sell |
407,922
-25,878
| -6% | -$284K | 0.01% | 330 |
|
|
2013
Q3 | $5.03M | Buy |
433,800
+97,200
| +29% | +$1.13M | 0.01% | 306 |
|
|
2013
Q2 | $3.77M | Buy |
+336,600
| New | +$3.77M | 0.01% | 341 |
|